Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Acute Promyelocytic Leukemia

fluorodeoxyglucose f18 has been researched along with Acute Promyelocytic Leukemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Bonnefoy, PB; Cornillon, J; Flandrin, P; Jacquet-Francillon, N; Prevot, N; Rigollet, L; Tavernier, E1
Cao, F; Li, J; Li, Y; Liu, X; Liu, Z; Wang, H; Wang, L; Zhao, H; Zhou, J1

Trials

1 trial(s) available for fluorodeoxyglucose f18 and Acute Promyelocytic Leukemia

ArticleYear
Homing of cytokine-induced killer cells during the treatment of acute promyelocytic leukemia.
    International journal of hematology, 2014, Volume: 100, Issue:2

    Topics: Adult; Antineoplastic Agents; Brain; Cell Movement; Cell Tracking; Cytokine-Induced Killer Cells; Cytotoxicity, Immunologic; Female; Fluorodeoxyglucose F18; Humans; Immunotherapy, Adoptive; Leukemia, Promyelocytic, Acute; Liver; Lung; Male; Middle Aged; Pelvic Bones; Positron-Emission Tomography; Remission Induction; Spine; Spleen; Treatment Outcome

2014

Other Studies

1 other study(ies) available for fluorodeoxyglucose f18 and Acute Promyelocytic Leukemia

ArticleYear
Utility of 18F-FDG PET/CT in medical care of a promyelocytic sarcoma.
    Current research in translational medicine, 2021, Volume: 69, Issue:2

    Topics: Fluorodeoxyglucose F18; Granulocyte Precursor Cells; Humans; Leukemia, Promyelocytic, Acute; Oncogene Proteins, Fusion; Positron Emission Tomography Computed Tomography; Sarcoma

2021